Myriad sues Ambry over cancer gene screening tests

10-07-2013

Biotech company Myriad Genetics has filed a patent infringement case against Ambry Genetic Corp for allegedly infringing 10 patents related to genetic diagnostic testing.


Myriad, Ambry, patent infringement, gene patents, diagnostic screening

LSIPR